Danavath Nagendra

Dr. Danavath Nagendra


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 March 2025 in Indian Journal of Critical Care Medicine
Verified
Journal Article
Open access
Nitin GuptaNitin Gupta
Nitin Gupta
VSVishal Shanbhag
Vishal Shanbhag
MVMuralidhar Varma
Muralidhar Varma
SRShwethapriya Rao
Shwethapriya Rao
PTPratibha Todur
Pratibha Todur
VBVinutha R Bhat
Vinutha R Bhat
Hypervirulent Klebsiella pneumoniae (HvKp) is a virulent strain associated with invasive infections. While initially community-acquired, hospital-acquired HvKp (HA-HvKp) and carbapenem-resistant HvKp (CR-HvKp) are increasingly reported. This meta-analysis evaluates the prevalence, risk factors, and clinical outcomes associated with HvKp, including CR-HvKp and HA-HvKp, among Kp infections. A systematic search of PubMed, Scopus, Embase, and Cochrane Library was conducted until December 2024. Observational studies comparing HvKp vs classical Kp (cKp), CR-HvKp vs carbapenem-sensitive HvKp (CS-HvKp), and HA-HvKp vs community-acquired HvKp (CA-HvKp) were included. Quality was assessed using the Joanna Briggs Critical Appraisal Tool, and pooled prevalence and odds ratios (ORs) with 95% confidence intervals (CIs) were calculated. Fifty studies with 6,663 participants were included. The HvKp prevalence was 33.0%, with most studies from Asia, predominantly China. Temporal analysis revealed an increase in HvKp prevalence (27.7% in 2006–2018 to 38.5% in 2019–2024). The CR-HvKp prevalence rose from 9.5% to 16.5% (2016–2024). The HA-HvKp prevalence increased from 25.9 to 47.1%. Key risk factors included diabetes mellitus (OR = 1.56), CA-Kp (OR = 2.59), and hypermucoviscous (HM)-phenotype (OR = 29.79). Complications included liver abscess (OR = 6.35), metastatic spread (OR = 4.74), meningitis (OR = 11.14), and septic shock (OR = 1.30). Mortality was higher in HvKp infections but not statistically significant (p = 0.219). HA-HvKp and immunosuppression were significant CR-HvKp risk factors, with CR-HvKp showing higher mortality. Diabetes mellitus, CA-Kp infections, and HM-phenotype are significant risk factors for HvKp. The rising prevalence of CR-HvKp and HA-HvKp highlights the need for early detection, infection control, and targeted treatment strategies. Nagendra D, Chaudhuri S, Gupta N, Shanbhag V, Eshwara VK, Rao S, et al. Prevalence, Risk Factors, and Clinical Outcomes of Hypervirulent Klebsiella pneumoniae Strains among Klebsiella pneumoniae Infections: A Systematic Review and Meta-analysis. Indian J Crit Care Med 2025;29(4):370–393.

26 June 2025 in Radiology Case Reports
Verified
Journal Article
Open access
DNDanavath Nagendra
Danavath Nagendra
NRNeeraja R
Neeraja R
VSVishal Shanbhag
Vishal Shanbhag
VEVandana Kalwaje Eshwara
Vandana Kalwaje Eshwara
KRKusugodlu Ramamoorthi
Kusugodlu Ramamoorthi
SCSouvik Chaudhuri
Souvik Chaudhuri
Hypervirulent Klebsiella pneumoniae (HvKp) is an emerging pathogen causing severe community-acquired infections, especially in diabetic patients, often with atypical presentations. We report a 63-year-old diabetic woman presenting with shoulder pain, in whom point-of-care ultrasound (POCUS) incidentally detected a pyogenic liver abscess; contrast-enhanced computed tomography confirmed impending rupture. Cultures identified a hypervirulent strain (positive string test, polymerase chain reaction confirmed iucA, rmpA, and peg-344), triggering severe systemic inflammation (CRP-274.9 mg/L, procalcitonin-10.43 mcg/L), respiratory failure, non-ST-elevation myocardial infarction (NSTEMI), and Takotsubo cardiomyopathy, despite antimicrobial sensitivity. Successful management included percutaneous drainage, escalation of antibiotics to meropenem, and cardiovascular support, resolving the infection by day 14. This case underscores POCUS’s role in detecting occult abscesses in high-risk diabetics, the link between hyperglycaemia and HvKp virulence, and the potential for HvKp-induced inflammation to precipitate cardiac complications, necessitating multidisciplinary care. The string test remains a pragmatic diagnostic tool in resource-limited settings, while early recognition, source control, and tailored therapy are critical to reducing morbidity and mortality in HvKp infections.

10 December 2025 in Infection
Verified
Journal Article
Open access
PDF file
DNDanavath Nagendra
Danavath Nagendra
VSVeena Suresh
Veena Suresh
AUAshritha A. Udupa
Ashritha A. Udupa
TSThejesh Srinivas
Thejesh Srinivas
VEVandana Kalwaje Eshwara
Vandana Kalwaje Eshwara
SCSouvik Chaudhuri
Souvik Chaudhuri
Background: Hypervirulent Klebsiella pneumoniae (HvKp) causes severe invasive infections, but the lack of a standardized definition complicates surveillance. The emergence of carbapenem-resistant HvKp (CR-HvKp) poses a “dual-risk” threat whose impact is poorly quantified. This meta-analysis aimed to determine pooled proportions of severe outcomes stratified by diagnostic criteria and quantify the mortality risk associated with CR-HvKp. Methods: Following PRISMA guidelines, we systematically searched five databases for studies published up to July 2025 reporting clinical outcomes of HvKp infection. A random-effects model was used to calculate pooled proportions of liver abscess, metastatic spread, septic shock, microbiological failure and mortality, with subgroup analyses by HvKp definition (phenotypic, molecular, combined, or clinical). Odds ratios (OR) for mortality in CR-HvKp versus carbapenem-susceptible (CS)-HvKp were pooled. Results: From 4413 records, 79 studies involving 4240 patients were included. The pooled proportion of liver abscess was 24% (95% CI 17–32%) and metastatic spread was 22% (95% CI 12–32%), both significantly influenced by the diagnostic criteria used (p < 0.0001). Pooled mortality for HvKp was 21% (95% CI 15–27%). In stark contrast, pooled mortality for CR-HvKp was 57% (95% CI 35–78%). The frequency of microbiological failure among HvKp infected patients was reported to be 39%. A meta-analysis of six studies revealed CR-HvKp infection was associated with over 12-fold higher odds of death compared to CS-HvKp infection. Conclusion: HvKp continues to cause severe invasive infections, though outcome estimates vary due to inconsistent definitions. Mortality increases markedly when carbapenem resistance co-exists with virulence, indicating that poor outcomes are driven by both pathogenic and resistance mechanisms. Standardized diagnostic criteria and expanded genomic surveillance are essential to improve epidemiological comparability and guide early detection and containment of high-risk HvKp strains.

10 July 2026 in Journal of Translational Medicine
Verified
Journal Article
Open access
TSThejesh Srinivas
Thejesh Srinivas
GHGagana Hanumaiah
Gagana Hanumaiah
DNDanavath Nagendra
Danavath Nagendra
SRShwethapriya Rao
Shwethapriya Rao
SCSouvik Chaudhuri
Souvik Chaudhuri
SKShobha U Kamath
Shobha U Kamath
Background: Acute respiratory distress syndrome (ARDS) is a biologically heterogeneous condition in which patients exposed to similar injurious stimuli often develop markedly different clinical trajectories and outcomes. While inflammation is central to ARDS pathogenesis, inflammatory burden alone does not fully explain the variability in disease progression, treatment response, or recovery. Emerging evidence suggests that immunometabolic reprogramming, characterized by increased glycolysis, impaired mitochondrial oxidative phosphorylation, and altered metabolite signalling, plays a critical role in shaping immune-cell activation, inflammatory persistence, and tissue repair during critical illness. Main body: This narrative review synthesizes current evidence linking immunometabolic reprogramming and mitochondrial dysfunction to the clinical heterogeneity observed in ARDS. During acute lung injury, immune and structural lung cells undergo metabolic shifts characterized by increased glycolysis, impaired mitochondrial oxidative phosphorylation, and accumulation of bioactive metabolites such as lactate, succinate, and extracellular adenosine triphosphate (ATP). Beyond reflecting metabolic stress, these metabolites function as signalling mediators that are associated with amplified inflammatory pathways, compromised alveolar-capillary barrier integrity, and sustained lung injury. Multi-omic studies further demonstrate that distinct metabolic signatures are associated with ARDS phenotypes, disease severity, and treatment responsiveness. We integrate these findings within the concept of metabolic resilience, defined as the host’s capacity to restore coordinated mitochondrial function, redox balance, and substrate utilization following inflammatory stress. Therapeutic strategies aimed at preserving mitochondrial function, restoring nicotinamide adenine dinucleotide (NAD⁺) homeostasis, and modulating maladaptive immunometabolic signalling may offer new avenues for precision-based interventions in ARDS. Conclusions: Immunometabolic reprogramming and mitochondrial dysfunction represent central biological axes linking cellular bioenergetics with clinical heterogeneity in ARDS. Understanding metabolic resilience may help refine phenotyping strategies and support development of metabolism-targeted therapies aimed at improving outcomes in this complex syndrome. Clinical trial number: Not applicable.

7 June 2025 in Clinical Epidemiology and Global Health
Verified
Journal Article
Open access
DNDanavath Nagendra
Danavath Nagendra
VEVandana Kalwaje Eshwara
Vandana Kalwaje Eshwara
SCSouvik Chaudhuri
Souvik Chaudhuri
VSVishal Shanbhag
Vishal Shanbhag
TSThejesh Srinivas
Thejesh Srinivas

22 January 2025 in Clinical Epidemiology and Global Health
Verified
Journal Article
Open access
TSThejesh Srinivas
Thejesh Srinivas
SRShwethapriya Rao
Shwethapriya Rao
GHGagana Hanumaiah
Gagana Hanumaiah
PTPratibha Todur
Pratibha Todur
SCSouvik Chaudhuri
Souvik Chaudhuri
PPPrabha Prakash
Prabha Prakash